Inclusion Criteria:~* Male or females~* Age ≥ 55 years, With mild-to-moderate AD, with MMSE between 18 and 26,
inclusive, MHIS score ≤ 4, Global CDR score of 1 or 2~* Who have a reliable informant/caregiver to accompany
patient to all clinic visits~* If using a symptomatic AD treatments, patients must be on stable dose for ≥ 6
months~
